Stocks›Healthcare›PACB

PACB

Pacific Biosciences of California, Inc.

NasdaqResearch view

Healthcare · Laboratory Analytical Instruments · Small-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$425.8M

Enterprise Value$1.3B

Income$-546.4M

Sales$160.0M

Book/sh$0.02

Cash/sh$0.21

Dividend TTM$0.00

Payout—

Employees—

IPO—

Quick Ratio4.47

Current Ratio5.15

Debt/Eq167.70

EPS (ttm)$-1.82

EPS this Y-14.5%

EPS past 3/5Y—

Sales past 3/5Y7.6%

EPS Y/Y TTM-14.5%

Sales Y/Y TTM3.9%

Shs Outstand310.83M

ROA-69.7%

ROE-10215.0%

ROIC-66.2%

Gross Margin28.6%

Oper. Margin-346.2%

Profit Margin-341.5%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$130.5M

2021

$128.3M

2022

$200.5M

2023

$154.0M

2024

$160.0M

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$130.5M	$128.3M	$200.5M	$154.0M	$160.0M
Gross Profit	$58.9M	$49.0M	$52.8M	$37.3M	$45.8M
Operating Income	$-210.4M	$-307.2M	$-334.5M	$-474.3M	$-553.9M
Net Income	$-181.2M	$-314.2M	$-306.7M	$-309.9M	$-546.4M
Diluted EPS	$-0.89	$-1.40	$-1.21	$-1.59	$-1.82
Operating Cash Flow	$-111.2M	$-263.2M	$-259.2M	$-206.1M	$-111.2M
Free Cash Flow	$-117.1M	$-280.0M	$-268.0M	$-212.2M	$-113.9M